Literature DB >> 12906063

Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers.

J Z Xiao1, S Kondo, N Takahashi, K Miyaji, K Oshida, A Hiramatsu, K Iwatsuki, S Kokubo, A Hosono.   

Abstract

The effects of milk products fermented by Bifidobacterium longum strain BL1, a probiotic strain, on blood lipids in rats and humans were studied. Rats were fed a cholesterol-enriched experimental diet, supplemented with lyophilized powders of 1) acid milk (control), 2) milk fermented with a mixed culture of ordinary yogurt starters composed of Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus (SL), and 3) bifidobacterium milk fermented with the probiotic B. longum strain BL1, respectively. The bifidobacterium milk feeding brought about significant lowering of the serum concentrations of total cholesterol, low-density lipoprotein cholesterol, and triglycerides, in comparison with the control, while no change in high-density lipoprotein cholesterol concentration was observed. On the other hand, supplementation with SL milk resulted in only slight, nonsignificant decreases in serum lipid concentrations in comparison with the control. In the human study, 32 subjects with serum total cholesterol ranging from 220 to 280 mg/dl were randomly assigned to two treatments: 1) intake of a low-fat drinking yogurt prepared with ordinary yogurt starters composed of S. thermophilus and L. delbrueckii subsp. bulgaricus (P-group) and 2) intake of a low-fat drinking yogurt prepared with the two ordinary yogurt starters plus B. longum strain BL1 (B-group). After intake for 4 wk at 3 x 100 ml/day, reduction of serum total cholesterol was observed in approximately half of the B-group subjects; a particularly significant decrease in serum total cholesterol was found among subjects with moderate hypercholesterolemia (serum total cholesterol > 240 mg/dl). However, the serum lipid concentrations in the P-group subjects were almost stable during the experimental periods. The present results indicate the potential of the probiotic B. longum strain BL1 in serum lipid improvement.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12906063     DOI: 10.3168/jds.S0022-0302(03)73839-9

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  66 in total

1.  Acquired tolerance to oxidative stress in Bifidobacterium longum 105-A via expression of a catalase gene.

Authors:  Jianlong He; Kouta Sakaguchi; Tohru Suzuki
Journal:  Appl Environ Microbiol       Date:  2012-02-03       Impact factor: 4.792

2.  The role of the gut microbiota in nonalcoholic fatty liver disease.

Authors:  Ahmed Abu-Shanab; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

3.  Lactobacillus acidophilus Increases the Anti-apoptotic Micro RNA-21 and Decreases the Pro-inflammatory Micro RNA-155 in the LPS-Treated Human Endothelial Cells.

Authors:  Mehdi Kalani; Hossein Hodjati; Mahdi Sajedi Khanian; Mehrnoosh Doroudchi
Journal:  Probiotics Antimicrob Proteins       Date:  2016-06       Impact factor: 4.609

Review 4.  Impact of functional foods on prevention of cardiovascular disease and diabetes.

Authors:  Geeta Sikand; Penny Kris-Etherton; Nancy Mariam Boulos
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

5.  Complete genome sequence of Bifidobacterium longum subsp. longum KACC 91563.

Authors:  Jun-Sang Ham; Taeheon Lee; Mi-Jeong Byun; Kyung-Tae Lee; Min-Kyung Kim; Gi-Sung Han; Seok-Geun Jeong; Mi-Hwa Oh; Dong-Hun Kim; Heebal Kim
Journal:  J Bacteriol       Date:  2011-07-08       Impact factor: 3.490

6.  A two-component regulatory system controls autoregulated serpin expression in Bifidobacterium breve UCC2003.

Authors:  Pablo Alvarez-Martin; Mary O'Connell Motherway; Francesca Turroni; Elena Foroni; Marco Ventura; Douwe van Sinderen
Journal:  Appl Environ Microbiol       Date:  2012-07-27       Impact factor: 4.792

Review 7.  Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings.

Authors:  Lay-Gaik Ooi; Min-Tze Liong
Journal:  Int J Mol Sci       Date:  2010-06-17       Impact factor: 5.923

Review 8.  ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy.

Authors:  Colleen T Cole-Jeffrey; Meng Liu; Michael J Katovich; Mohan K Raizada; Vinayak Shenoy
Journal:  J Cardiovasc Pharmacol       Date:  2015-12       Impact factor: 3.105

9.  Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content.

Authors:  Do Kyung Lee; Seok Jang; Eun Hye Baek; Mi Jin Kim; Kyung Soon Lee; Hea Soon Shin; Myung Jun Chung; Jin Eung Kim; Kang Oh Lee; Nam Joo Ha
Journal:  Lipids Health Dis       Date:  2009-06-11       Impact factor: 3.876

10.  Effects of isoflavone-supplemented soy yogurt on lipid parameters and atherosclerosis development in hypercholesterolemic rabbits: a randomized double-blind study.

Authors:  Daniela C U Cavallini; Dulcinéia S P Abdalla; Regina C Vendramini; Raquel Bedani; Laura Q Bomdespacho; Nadiége D Pauly-Silveira; Graciela F de Valdez; Elizeu A Rossi
Journal:  Lipids Health Dis       Date:  2009-10-08       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.